Gardasil DTC driving force behind Merck expense increase

Gardasil DTC was the chief factor behind a 21% increase in Merck marketing and administrative expenses for the fourth quarter of 2006, followed by consumer promotion of Zostavax and spending on the Januvia launch, said CEO Dick Clark in a Q4 earnings report.

You must be a registered member of MMM to post a comment.

Next Article in Pharmaceutical